FOXF2 and cancer: Bothdownregulation of anti-apoptotic targets as well as activation of proliferativemetabolism have been observed as mechanisms contributing to MAPKi-R.Downregulation of FOXF2 has been shown to promote cancer progression, EMT, andmetastatic invasion [48].